JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by van der Sman, J.
Right arrow Articles by Lam, E. W.-F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van der Sman, J.
Right arrow Articles by Lam, E. W.-F.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J Biol Chem, Vol. 274, Issue 17, 12009-12016, April 23, 1999

Modulation of E2F Complexes during G0 to S Phase Transition in Human Primary B-lymphocytes

Jeroen van der SmanDagger , N. Shaun B. Thomas§, and Eric W.-F. LamDagger

From the Dagger  Ludwig Institute for Cancer Research and Section of Virology and Cell Biology, Imperial College School of Medicine at St Mary's, London W2 1PG and § Department of Haematology, University College London Medical School, London WC1E 6HX, United Kingdom

The pocket protein-E2F complexes are convergence points for cell cycle signaling. In the present report, we identified and monitored the pocket protein-E2F complexes in human primary B-lymphocytes after activation by phorbol 12-myristate 13-acetate. Consistent with previous data from human and mouse fibroblasts and T-lymphocytes, E2F4 and DP1 form the predominant E2F heterodimers both in G0 and G1 phases of the human B-lymphocyte cell cycle, whereas E2F1 and -3 are first detected in late G1, and their expression levels increase towards S phase. Intriguingly, the major E2F complex that we detected in quiescent human B-lymphocytes is consisted of pRB, E2F4, and DP1. Though the levels of DP1 and -2 increase when cells progress from G0 to S, the proportion of DP1 to DP2 remains relatively constant during the cell cycle. We also observed an increase in electrophoretic mobility of the predominant E2F components, DP1 and E2F4, as B-lymphocytes progressed from G0 into early G1. This increase in mobility was attributable to dephosphorylation, as lambda  phosphatase treatment could convert the slower migrating forms into the corresponding faster mobility forms. We further demonstrated that this change in phosphorylation status correlates with a decrease in DNA binding activity. This modulation of DNA binding activity mediated through the dephosphorylation of DP1 and E2F4 could help to explain the lack of in vivo DNA footprinting in late G1 and S phases of gene promoters negatively regulated through E2F sites and suggests a novel mechanism for controlling E2F transcriptional activity during the transition from quiescence to proliferation.


Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Immunol.Home page
R. Panchanathan, H. Xin, and D. Choubey
Disruption of Mutually Negative Regulatory Feedback Loop between Interferon-Inducible p202 Protein and the E2F Family of Transcription Factors in Lupus-Prone Mice
J. Immunol., May 1, 2008; 180(9): 5927 - 5934.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
D. L. Kienle, C. Korz, B. Hosch, A. Benner, D. Mertens, A. Habermann, A. Krober, U. Jager, P. Lichter, H. Dohner, et al.
Evidence for Distinct Pathomechanisms in Genetic Subgroups of Chronic Lymphocytic Leukemia Revealed by Quantitative Expression Analysis of Cell Cycle, Activation, and Apoptosis-Associated Genes
J. Clin. Oncol., June 1, 2005; 23(16): 3780 - 3792.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
A. Mohamedali, I. Soeiro, N. C. Lea, J. Glassford, L. Banerji, G. J. Mufti, E. W.-F. Lam, and N. S. B. Thomas
Cyclin D2 controls B cell progenitor numbers
J. Leukoc. Biol., December 1, 2003; 74(6): 1139 - 1143.
[Abstract] [Full Text]


Home page
BloodHome page
C. Korz, A. Pscherer, A. Benner, D. Mertens, C. Schaffner, E. Leupolt, H. Dohner, S. Stilgenbauer, and P. Lichter
Evidence for distinct pathomechanisms in B-cell chronic lymphocytic leukemia and mantle cell lymphoma by quantitative expression analysis of cell cycle and apoptosis-associated genes
Blood, May 29, 2002; 99(12): 4554 - 4561.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
G. J. P. L. Kops, R. H. Medema, J. Glassford, M. A. G. Essers, P. F. Dijkers, P. J. Coffer, E. W.-F. Lam, and B. M. T. Burgering
Control of Cell Cycle Exit and Entry by Protein Kinase B-Regulated Forkhead Transcription Factors
Mol. Cell. Biol., April 1, 2002; 22(7): 2025 - 2036.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. Schrantz, G. E. Beney, M. T. Auffredou, M. F. Bourgeade, G. Leca, and A. Vazquez
The Expression of p18INK4 and p27kip1 Cyclin-Dependent Kinase Inhibitors Is Regulated Differently During Human B Cell Differentiation
J. Immunol., October 15, 2000; 165(8): 4346 - 4352.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
S. J. Advani, R. R. Weichselbaum, and B. Roizman
E2F Proteins Are Posttranslationally Modified Concomitantly with a Reduction in Nuclear Binding Activity in Cells Infected with Herpes Simplex Virus 1
J. Virol., September 1, 2000; 74(17): 7842 - 7850.
[Abstract] [Full Text]


Home page
Mol. Cell. Biol.Home page
J. Wells, K. E. Boyd, C. J. Fry, S. M. Bartley, and P. J. Farnham
Target Gene Specificity of E2F and Pocket Protein Family Members in Living Cells
Mol. Cell. Biol., August 15, 2000; 20(16): 5797 - 5807.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
E. W.-F. Lam, J. Glassford, L. Banerji, N. S. B. Thomas, P. Sicinski, and G. G. B. Klaus
Cyclin D3 Compensates for Loss of Cyclin D2 in Mouse B-lymphocytes Activated via the Antigen Receptor and CD40
J. Biol. Chem., February 4, 2000; 275(5): 3479 - 3484.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. S. Carroll, O. W. J. Prall, E. A. Musgrove, and R. L. Sutherland
A Pure Estrogen Antagonist Inhibits Cyclin E-Cdk2 Activity in MCF-7 Breast Cancer Cells and Induces Accumulation of p130-E2F4 Complexes Characteristic of Quiescence
J. Biol. Chem., December 1, 2000; 275(49): 38221 - 38229.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. J. A. D'Souza, A. Pajak, K. Balazsi, and L. Dagnino
Ca2+ and BMP-6 Signaling Regulate E2F during Epidermal Keratinocyte Differentiation
J. Biol. Chem., June 22, 2001; 276(26): 23531 - 23538.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
F. J. Lemoine and S. J. Marriott
Accelerated G1 Phase Progression Induced by the Human T Cell Leukemia Virus Type I (HTLV-I) Tax Oncoprotein
J. Biol. Chem., August 17, 2001; 276(34): 31851 - 31857.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1999 by the American Society for Biochemistry and Molecular Biology.